Medicare will only cover a drug for Alzheimer’s disease for patients in clinical trials, President Joe Biden’s administration announced on April 7.
The drug, Aduhelm, is made by Biogen.
Aduhelm, Biogen's approved drug for early Alzheimer's disease, is seen at Butler Hospital, one of the clinical research sites in Providence, R.I., on June 16, 2021. Jessica Rinaldi/Pool via Reuters
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
